At what enterprise value was LVL MEDICAL GERMANY acquired in 2012?

During the acquisition of LVL MEDICAL GERMANY by MANAGEMENT & PRIVATE INVESTORS in 2012, the transaction's Enterprise Value is estimated to be in the range of 50M - 150M EUR.

What was the EV/EBITDA of LVL MEDICAL GERMANY when it was acquired by MANAGEMENT & PRIVATE INVESTORS?

The estimated EV/EBITDA multiple for LVL MEDICAL GERMANY is in the range of 10x - 18x.

What was the revenue of LVL MEDICAL GERMANY at the time of the deal?

The revenue of LVL MEDICAL GERMANY at the time of the deal is estimated to be in the range of 50M - 100M EUR.

What was the EBITDA of LVL MEDICAL GERMANY during the acquisition?

LVL MEDICAL GERMANY's EBITDA is estimated to be in the range of 5M - 25M EUR.

How is the data for the LVL MEDICAL GERMANY acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the LVL MEDICAL GERMANY deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.agefi.fr/news/entreprises/le-rachat-de-lvl-medical-par-air-liquide-rend-le-secteur-plus-speculatif

← DATABASE

Home Database Healthcare & PharmaLVL MEDICAL GERMANY

07/2012

LVL MEDICAL GERMANY acquired by MANAGEMENT & PRIVATE INVESTORS

GERMANY Health Providers / Outpatient Care EV 50M - 150M EUR

Context

Concomitantly with the Air Liquide acquisition of LVL Médical's French activities, the Lavorel family agreed to acquire 100% of LVL Médical Allemagne from LVL Médical Groupe. The transaction was structured as a mandatory prerequisite to the Air Liquide deal, as the latter's acquisition perimeter was explicitly limited to the French operations. The carve-out ensures a clean separation between the French and German businesses, with Air Liquide retaining full focus on the French home healthcare market and the Lavorel family continuing to develop the German operations autonomously. The transaction was agreed upon on a concurrent basis with the broader LVL Médical deal, with both closings expected in Q3 2012.

LVL MEDICAL GERMANY, which reported an EBITDA margin of in 2009, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Healthcare & Pharma sector (15.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

LVL Medical Allemagne is the German subsidiary of LVL Médical Groupe SA, a French home healthcare services group. Operating on the same model as its French parent, the German entity provides home-based medical services and equipment to patients suffering from chronic conditions, developing an intensive care delivery model structured around small local units combining strong field presence, patient proximity, and high-level technical services.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2009

2008

Similar deals in Health Providers

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
01/2015	CERBA HEALTHCARE	NOVESCIA	FRANCE	Labs (Biology)
10/2014	WATERLAND	MEDIAN KLINIKEN	GERMANY	Clinics / Hospitals
09/2014	EURAZEO	COLISÉE	FRANCE	Nursing Homes
06/2014	PAI PARTNERS	DOMUSVI	FRANCE	Nursing Homes
03/2014	EQT PARTNERS	I-MED RADIOLOGY NETWORK	AUSTRALIA	Radiology
06/2012	AIR LIQUIDE	ORKYN (EX LVL MEDICAL)	FRANCE	Outpatient Care
12/2010	SAGA GROUP	NESTOR HEALTHCARE GROUP	UNITED KINGDOM	Outpatient Care
06/2010	PAI PARTNERS	CERBA HEALTHCARE	FRANCE	Labs (Biology)
05/2010	HG CAPITAL	FRÖSUNDA	SWEDEN	Healthcare Facilities
03/2010	BRIDGEPOINT	CARE UK	UNITED KINGDOM	Nursing Homes

REFERENCES

Valuation range: EV 50M - 150M EUR

Revenue range: 50M - 100M EUR

EBITDA range: 5M - 25M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of LVL MEDICAL GERMANY by MANAGEMENT & PRIVATE INVESTORS are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.